AAT-AD/PD Focus Meeting 2018

AAT-AD/PD Focus Meeting 2018
This Alzheimer’s disease and Parkinson’s disease conference will present all the latest breakthroughs in treatment, translational Research and Development, early diagnosis, drug development and clinical trials

The AAT-AD/PD Focus Meeting 2018 in Torino, Italy is a new joint meeting between the International Geneva/Springfield Symposium on Advances in Alzheimer Therapy (AAT) and AD/PD.

This AAT-AD/PD focus meeting will present all the latest breakthroughs in treatment, translational Research and Development, early diagnosis, drug development and clinical trials in Alzheimer’s, Parkinson’s and other related neurological disorders.

SciTech Europa Quarterly is acting as a media partner for the conference, with coverage to be included both online and in the 27th edition of the publication.

A central theme at the conference will be to advance innovative strategies in therapy and prevention, clinical trials and diagnostic markers. This conference will focus on driving successful collaborations among academia and industry, leading to the development of innovative drugs and ultimately providing for a better future for patients and families affected by neurodegenerative diseases.

As well as unparalleled opportunities for networking with 1,200 participants and learning about the latest developments in the field, at the AAT-AD/PD Focus Meeting delegates will visit the historic city of Torino – the first capital city of Italy and an important business and cultural centre in the country.

The Conference, being in Torino, is dedicated to the Nobel Laureate Rita Levi-Montalcini, who was born and worked in Torino.

The organising committee for the conference said: “We, the organizing committee, see this as a great opportunity to create continuity in the field from year to year with a strong emphasis on therapy on alternate years. We hope to harness the strengths of both conferences and offer a platform to highlight the hottest and most relevant topics, both in Alzheimer’s and Parkinson’s therapies as well as related neurological diseases.”

Adding: “This Conference provides a vital opportunity for the international community to come together and strive for better advancements in the year leading up to AD/PDTM 2019 in Lisbon, Portugal.”

The city is full of history which can be explored through its 11 miles of arcades and the neat grid of streets drawn up by the ancient Romans, layered with wide avenues and grand squares.

The programme for the Conference is now online. The deadline is approaching fast with only a month left to register, and there are still places at the conference left.

LEAVE A REPLY

Please enter your comment!
Please enter your name here